In Angina, Gene Therapy Coaxes Heart Vessel Growth

The experimental new approach, delivered to the heart of those with angina after bypass surgery, showed evidence of restored blood flow 1 year later.

Related Keywords

North Carolina ,United States ,California ,Cincinnati ,Ohio ,Timothy Henry ,Kenta Nakamura ,Thomas Povsic ,Duke Clinical Research Institute In Chapel Hill ,Society For Cardiovascular Angiography ,University Of Washington School Medicine ,Edyth Lindner Center ,Washington School ,Cardiovascular Angiography ,Duke Clinical Research Institute ,Chapel Hill ,Christ Hospital ,Angina ,Angina Pectoris ,Vegf Inhibitor ,Vascular Endothelial Growth Factor Inhibitor ,Coronary Artery Bypass Graft ,Coronary Artery Bypass Surgery ,Coronary Artery Bypass Graft Surgery ,Cv Risk ,Cardiovascular Risk ,V Risk Factors ,Cardiovascular Risk Factors ,Cardiovascular Risk Management ,Heart ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,